Fig. 5From: Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulationsImpairment of ability to concentrate before (upper panel) and after treatment (lower panel) with individual ambroxol preparations and in the overall group. Data are % of participants within a categoryBack to article page